NDMA/NDEA Testing | Sana Pharma
NDMA/NDEA Testing
Home » SANA Pharma News » NDMA/NDEA Testing
Thursday, July 4, 2019

Sana Pharma has been approved by Jordan FDA as third party analytical site for NDMA/NDEA carcinogenic of Valsartan family.  

Back »
For further information, please contact us at:

Sana Pharma Industries
P.O.Box:144 Amman 11934 Jordan
Office: + 962 6 5233349
Fax: + 962 6 5233349
Email: info@sana-pharma.com

© 2016 Developed by Blue Ray for Web Solutions. All rights reserved
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.